What are your top takeaways from AAAAI 2026?

The presentations related to the treatment of systemic mastocytosis (SM) were the highlight of the AAAAI meeting. They demonstrated that patients with non-advanced SM (NonAdvSM) can achieve complete remission of SM where WHO diagnostic criteria are no longer met. The rate of remission (where WHO dia...

• Neuroimmunology conference on Sunday, which addressed the interaction of sensory neuronal cells and mast cells.
• Plenary session on AI – positive and negative benefits. Cognitive deskilling is a problem.
• Abstract on CRISPR data results for treatment of HAE – breakthrough results on potential HAE cure.